Latest News

STAT Plus: All talk, no M&A makes for a down JPM Day

SAN FRANCISCO — Monday at the J.P. Morgan Healthcare Conference came and went without significant buyouts or deals, and so, biotech stocks fell.

The sector’s most closely followed stock index closed down 2%. Gene therapy developer Uniqure (QURE) — high on many investors’ takeout list — was among the sector’s biggest Monday losers. 

Continue to STAT Plus to read the full story…

Source link

Related posts

Virtual Reality Used to Spot Early Signs of Alzheimer’s Disease


Insights & Forecast with Potential Impact of COVID-19 – Global Cervical Cancer Therapeutics Market 2020-2024 | Evolving Opportunities with Amgen Inc., and Biocon Ltd. | Technavio


Edwards SAPIEN 3 Ultra Transcatheter Valve for Severe Aortic Stenosis Cleared in Europe


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World